Recently, it has been reported that antioxidants inhibit enzymes such as butyrylcholinesterase (BChE), acetylcholinesterase (AChE), α-amylase, carbonic anhydrase, and α-glycosidase, which are associated with diseases such as type 2-DM (T2DM), Alzheimer’s disease (AD), and glaucoma [15,16,17]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.